Synthesis and antitumor activities of derivatives of the marine mangrove fungal metabolite deoxybostrycin

12Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Deoxybostrycin (1) is an anthraquinone compound derived from the marine mangrove fungus Nigrospora sp. No. 1403 and has potential to be a lead for new drugs because of its various biological properties. A series of new derivatives (2- 22) of deoxybostrycin were synthesized. The in vitro cytotoxicity of all the new compounds was tested against MDA-MB-435, HepG2 and HCT-116 cancer cell lines. Most of the compounds exhibit strong cytotoxicity with IC50 values ranging from 0.62 to 10 μM. Compounds 19, 21 display comparable cytotoxicity against MDA-MB-435 to epirubicin, the positive control. The primary screening results indicate that the deoxybostrycin derivatives might be a valuable source of new potent anticancer drug candidates. © 2012 by the authors.

Cite

CITATION STYLE

APA

Chen, H., Zhu, X., Zhong, L. L., Yang, B., Li, J., Wu, J. H., … She, Z. G. (2012). Synthesis and antitumor activities of derivatives of the marine mangrove fungal metabolite deoxybostrycin. Marine Drugs, 10(12), 2715–2728. https://doi.org/10.3390/md10122715

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free